Proteome shares rise on EU funding; Prostate marker could help surgery decisions;

> A team of researchers in Ireland have validated a prostate biomarker that could support accurate preoperative staging of prostate cancer, helping doctors make better treatment decisions. Abstract

> Astute Medical expects to launch its NephroCheck Test, a biomarker-based test for acute kidney injury in critically ill patients, in Europe this year. Press release

> Biomarker company Proteome Sciences' ($PRM.L) shares have risen on the news that Euro-HYP-1, the consortium of academic, clinical and industrial European partners that includes Proteome, has received an €11 million ($14.6 million) award for research into stroke. Article

> In non-small cell lung cancer patients treated with the targeted drug erlotinib, finding new lesions using 18F-FDG PET is a potential surrogate biomarker for survival. Abstract

> Researchers have shown the first signs that the Wnt signaling pathway may include a biomarker for scleroderma but also said that more research is needed. Press release

> A blood test based on ischemia-modified albumin is a potential diagnostic biomarker in diabetic ketosis. Abstract

> Serum biomarkers were predictive of higher frequencies of seizures in people with temporal lobe epilepsy. Abstract

> DNA methylation (the addition of small groups on DNA strands) may be a biomarker for schizophrenia. Abstract

> Restore Biodiagnostics has received a National Institutes of Health grant to develop a rapid point of care saliva test to assess stress levels, based on the stress biomarker cortisol. Press release

> NextGen Sciences Dx has filed for intellectual property on a combination of protein biomarkers with the potential for diagnosing changes in cognition for patients with early-stage dementia. Press release

> Protagen and the University of Tübingen are collaborating to develop multiplex assays for diagnosing autoimmune diseases and cancer. Article

> Taiwanese university National Cheng Kung University has signed a memorandum of understanding with Ohio State University College of Pharmacy to develop diagnostic markers and therapeutic agents for pancreatic cancer. Press release

> Finding the peptide megalin in the urine could mark the development and severity of diabetic nephropathy. Article

> HealthLinx is carrying out a study to support the South Korean submission of its biomarker-based ovarian cancer diagnostic test, OvPlex. Article

And Finally… David Alland of UMDNJ has received a tuberculosis biomarkers grant from the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program. Article

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.